← Back to Clinical Trials
Recruiting NCT07447609

NCT07447609 THE EFFECT OF REIKI ON BREASTFEEDING, PAIN AND COMFORT AFTER CESAREAN SECTION

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07447609
Status Recruiting
Phase
Sponsor Saglik Bilimleri Universitesi
Condition Postpartum Comfort
Study Type INTERVENTIONAL
Enrollment 99 participants
Start Date 2025-01-15
Primary Completion 2026-05-20

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
reikisham reiki

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 99 participants in total. It began in 2025-01-15 with a primary completion date of 2026-05-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

EFFECT OF REİKİ APPLİED DURİNG THE POSTPARTUM PERİOD ON BREASTFEEDİNG, PAİN, AND COMFORT IN WOMEN WHO DELİVERED BY CESAREAN SECTİON The aim of this randomized controlled trial is to determine the effect of Reiki applied to volunteer women after cesarean section on breastfeeding, pain, and comfort in the postpartum period. The main questions it aims to answer are: Is there a difference in postpartum breastfeeding, pain, and comfort between the group receiving Reiki and the group receiving standard care? Is there a difference in postpartum breastfeeding, pain, and comfort between the group receiving Reiki and the group receiving Sham Reiki? Participants will receive Reiki six times postpartum: three times one-on-one during their hospital stay, and remotely in the second, third, and fourth weeks. The control group will receive standard care. The Sham Reiki group will receive Reiki points applied by a person without Reiki knowledge.

Eligibility Criteria

Inclusion Criteria: * Mothers aged 18 and over, * Literate in Turkish, * Non-smoker, non-drug user, * Gave birth by cesarean section at term, * Baby with them after birth, * Not using any breast milk-increasing medication, vitamins, or supplements, * Baby's birth weight between 2500-4000 grams, * Baby's Apgar score at least seven points at 1 and 5 minutes, * Having had a cesarean section under spinal anesthesia, * Those who agree to participate in the study. Exclusion Criteria: * Preeclampsia/eclampsia, active postpartum hemorrhage, sepsis/fever ≥38°C, * Need for intensive care, * Birth before 37 weeks, * Serious neonatal problems, * Baby arriving at the ward after mother (follow-up in neonatal intensive care unit without hospitalization after birth), * Excessive sedation due to analgesia, * Communication difficulties, * Markedly negative attitude towards Reiki.

Contact & Investigator

Central Contact

Gozde G Cakmak, specialist nurse, phd student

✉ gzdnzm@gmail.com

📞 +905553603460

Principal Investigator

Gulten Guvenc, prof. dr.

STUDY DIRECTOR

sağlık bilimleri university Faculty of Nursing

Frequently Asked Questions

Who can join the NCT07447609 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Postpartum Comfort. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07447609 currently recruiting?

Yes, NCT07447609 is actively recruiting participants. Contact the research team at gzdnzm@gmail.com for enrollment information.

Where is the NCT07447609 trial being conducted?

This trial is being conducted at Samsun, Turkey (Türkiye).

Who is sponsoring the NCT07447609 clinical trial?

NCT07447609 is sponsored by Saglik Bilimleri Universitesi. The principal investigator is Gulten Guvenc, prof. dr. at sağlık bilimleri university Faculty of Nursing. The trial plans to enroll 99 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology